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Abstract 
SPG45 is a rare form of autosomal recessive spastic paraplegia associated with mental 
retardation. Detailed phenotyping and mutation analysis was undertaken in three individuals 
with SPG45 from a consanguineous family of Arab Muslim origin. Using whole-exome 
sequencing, we identified a novel homozygous missense mutation in NT5C2 (c.1379T>C; 
p.Leu460Pro).  Our data expand the molecular basis of SPG45, adding the first missense 
mutation to the current database of nonsense, frameshift and splice site mutations. NT5C2 
mutations seem to have a broad clinical spectrum and should be sought in patients manifesting 
either as uncomplicated or complicated HSP. 
 
Keywords:  Hereditary spastic paraplegias; SPG45; Exome sequencing; NT5C2 
 
  
Straussberg et al. 
4 
 
INTRODUCTION 
Hereditary spastic paraplegias (HSPs) comprise a group of genetically heterogeneous 
neurodegenerative disorders presenting with progressive spasticity in the lower limbs. The 
prevalence is between 3 and 10 per 100,000 people [de Souza et al., 2017]. Pathological 
findings show axonal degeneration resulting in loss of corticospinal tract function. Clinically, 
HSPs are divided into two major entities, uncomplicated and complicated, the latter including 
additional manifestations such as intellectual disability, epilepsy, optic atrophy, deafness, 
peripheral neuropathy, ataxia and skin abnormalities. HSPs also vary genetically with 
autosomal dominant, autosomal recessive and X-linked modes of inheritance. Autosomal 
recessive inheritance is generally associated with complicated HSPs. 
Autosomal recessive spastic paraplegia (SPG45) with intellectual disability was 
mapped to 10q24.3-q25.1 by Dursun et al. in 2009. Some five years later, in those same 
affected subjects, Novarino et al. identified a homozygous truncating mutation in NT5C2 
[Novarino et al., 2014]. Their report also described four additional families with SPG45 in 
whom homozygous mutations were also found in NT5C2. The function of the 5'-Nucleotidase 
Cytosolic II protein encoded by NT5C2 involves maintenance of a constant composition of 
intracellular purine/pyrimidine nucleotides in cooperation with other nucleotidases, 
preferentially hydrolyzing inosine 5-monophosphate and other purine nucleotides [Camici et 
al., 2010]. NT5C2 has also been implicated in schizophrenia, leukemia and hypertension 
[Aberg et al., 2013; Meyer et al., 2013; Kelly et al., 2013], but the loss-of-function (frameshift, 
nonsense, splice site) mutations identified by Novarino et al. establish this as the causative 
gene in SPG45. Underscoring this association, a further autosomal recessive splice site 
mutation in NT5C2 has also been reported in two more siblings with SPG45 [Elsaid et al., 
2017]. 
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We herein describe the clinical, radiologic and genetic findings in three individuals of 
Arab Muslim origin with SPG45 belonging to a consanguineous family who harbor a new 
mutation in NT5C2, the first missense mutation in this disorder. The patients manifested a 
phenotype of complicated HSP with moderate intellectual disability, attention deficit disorder 
and each individual had significant corpus callosum and white matter pathology. We compare 
our findings to the previously described six families.  
 
SUBJECTS AND METHODS 
Three affected individuals born to parents of Israeli Arab Muslim descent with known 
consanguinity and originating from the same village presented with motor, developmental, and 
intellectual abnormalities (pedigree is shown in Fig. 1a). Assessments and investigations were 
made between 14 and 19 years of age. Informed consent was obtained from all 14 members of 
the family included in the study. The study was approved by the Helsinki Committee in Rabin 
Medical Center. 
There was no history of any complications in pregnancy. Delivery was normal in two 
subjects, although case IV:8 suffered from meconium aspiration. According to the parents, all 
three affected individuals (IV:7, IV:8 and IV:10) developed normally until 6, 9 and 12 months 
of age, respectively. Because of delayed milestones the children were referred to physiotherapy 
and at that time shortening and tension in the Achilles' tendons bilaterally was noticed in 
addition to lower limb spasticity. Subject IV:8 achieved standing at the age of 2 years and 
examination at that time showed spastic tone with scissoring, such that she could only stand on 
her toes. The children (IV:7, IV:8 and IV:10) achieved independent walking at 3 and 1/2 years, 
3 years and 4 and 1/2 years, respectively. Language acquisition was also delayed; words were 
first spoken around 2 years. Currently, they all have moderate intellectual disability and 
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attention deficit disorder with hyperactivity and receive treatment with methylphenidate. 
However, they can all walk independently using specially adapted crutches, although all have 
undergone several tendon release operations. Case IV:8 also had eye surgery for strabismus. 
Individuals IV:7 and IV:10 are toilet trained, but case IV:8 has ongoing primary nocturnal 
enuresis. 
Regarding neurological features, individuals IV:7, IV:8 and IV:10 were examined at 
the age of 16 and 1/2, 14 and 19 years, respectively. All were normocephalic (25th, 45th and 
30th head circumference percentile). Cranial nerves, light and deep sensation, muscle strength, 
cerebellar functions, vibration and proprioception were all normal. However, hypertonia was 
noted in the lower limbs, the patellar reflexes were very brisk and clonus was elicited. Achilles' 
tendons were tight. Babinski’s sign was extensor bilaterally in all subjects. There was spastic 
gait with crouch and circumduction as well as foot inversion with flat feet but no contractures 
were present. All three subjects underwent brain MRI and in each case the corpus callosum 
was thin all along but more so in the posterior aspect of the body and splenium, and abnormal 
signal intensities were observed in the periventricular white matter (Fig. 1b). Case IV:7 also 
had a normal spinal MRI (not performed in the others).  
We performed exome sequencing in nine individuals from this pedigree (Fig. 1a), two 
of whom are affected (IV:8 and IV:10). Variant calling was performed with a previously 
published in-house pipeline [Lee et al., 2017]. More than 4.9 Gb of sequence was generated 
per sample, such that >94% of the target exome was present at >20-fold coverage, and >98% 
was present at 5-fold coverage (Supplementary Tables 1 and 2). Because both affected 
individuals are offspring of consanguineous marriages, we evaluated variants consistent with 
a model of rare autosomal-recessive inheritance, focusing on homozygous predicted protein 
altering substitutions and indels that were shared by both affected members. We filtered 
variants to retain variants that had a minor allele frequency <0.005 in each of the 1000 Genomes 
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Project, ExAC and our in-house database of in excess of 6000 exomes. We further filtered their 
variant profiles by excluding all homozygous variants that were not shared by their parents in 
a heterozygous state, and all homozygous variants that were present in their unaffected siblings. 
Variants highlighted from exome analysis were confirmed by Sanger sequencing. 
 
RESULTS 
Our stepwise filtering strategy revealed a single homozygous missense variant in 
NT5C2 (c.1379C>T; p.Leu460Pro), which is predicted to be “deleterious” by the CADD 
pathogenicity software tool (CADD score 32) (Supplementary Table 3). Segregation analysis 
of the c.1379C>T substitution in all available members of the extended pedigree, including an 
additional affected individual (IV:7), confirmed the recessive inheritance of the variant.  
To the best of our knowledge, we report the 7th family with SPG45 with NT5C2 gene 
pathology, with our report containing the first description of a missense mutation 
(p.Leu460Pro). Details of our patients and those previously published are shown in 
Supplementary Table 4.  
 
DISCUSSION 
Dursun et al. reported a consanguineous Turkish family in which five individuals had 
a form of complicated spastic paraplegia with mental retardation. Novarino et al. studied the 
family reported by Dursun et al. and eight individuals from four additional families with 
SPG45. Recently, Elsaid et al., reported two additional brothers of a consanguineous Qatari 
family harboring a novel homozygous NT5C2 splice site mutation. They were unique to all 
other patients reported so far with SPG45 in that they displayed persistent early truncal 
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hypotonia, dysarthria and variable-sized patches of skin brownish discoloration that appeared 
at 6 years of age.  
Our family is similar to the family reported by Dursun et al. in that both families exhibit 
a phenotype of complicated hereditary spastic paraplegia due to the intellectual disability 
manifesting in all the affected individuals. However, our patients manifested at an earlier age. 
All of them had ADHD and were treated by methylphenidate and all had pathological brain 
MRIs as opposed to the normal MRI reported in one of the individuals described by Dursun et 
al. The patients reported by Novarino et al. had a phenotype of pure uncomplicated hereditary 
spastic paraplegia because they had normal intelligence; however, their MRIs displayed 
significant pathology in the structure of the corpus callosum similar to our patients.  Elsaid's 
patients display a phenotype of complicated HSP [Elsaid et al., 2017]. 
Pathologies of the corpus callosum are found in many HSPs (Supplementary Table 5). 
The most prevalent is autosomal recessive SPG11 – hereditary spastic paraplegia with thin 
corpus callosum. Next in frequency is SPG15. Ruano et al. reported the prevalence of 
autosomal dominant HSP to range from 0.5 to 5.5/10(5) and that of autosomal recessive HSP 
from 0.0 to 5.3/10(5) with pooled averages of 1.8/10(5) and 1.8/10(5), respectively. They 
surveyed 22 prevalence studies, reporting on 14,539 patients from 6 countries [Ruano et al., 
2014]. These patients display complicated HSP phenotype. Both SPG11 and SPG15 proteins 
interact with a 4-protein complex designed AP5 (adapter protein 5), which localizes to small 
intracellular membrane-bound vesicles named endosomes [Hirst et al., 2011; Hirst et al., 2013]. 
Although AP5's function is not fully understood, it probably acts to remove membrane cargoes 
away from the endosomal compartment [Hirst et al., 2011; Hirst et al., 2013]. Twenty-one of 
the HSPs involve thin corpus callosum, thus reflecting an important association between central 
and peripheral nervous system pathology.  
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NT5C2 encodes a downstream cytosolic purine nucleotide 5' phosphatase. Purine 
nucleotides are neuroprotective and have a major role in the pathogenesis of brain ischemia 
and the developing brain [Thauerer et al., 2012]; thus, changes in their levels could sensitize 
neurons to stress and insult. 
In conclusion, we have presented the 7th family with a novel mutation in NT5C2 causing 
SPG45. This disorder may manifest either as pure or complicated HSP with or without typical 
MRI findings. 
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Fig. 1 Pedigree structure and Brain MRI scans. a Segregation analysis of the c.1379T>C 
(p.Leu460Pro) mutation. b Brain MRI Scans of three affected individuals. Subject IV:7. 
Sagittal T1 Weighted Imaging (T1WI) demonstrates a thin corpus callosum (left panel). On 
axial T2WI (middle panel) and FLAIR (fluid attenuation inversion recovery) abnormal 
periventricular perioccipital signal intensities are seen (right panel). Subject IV:8. Sagittal T1 
Weighted Imaging (T1WI) demonstrates a thin corpus callosum (left panel). On axial T2WI 
abnormal periventricular signal intensities are seen (right panel). Subject IV:10. Sagittal T1 
Weighted Imaging (T1WI) demonstrates a thin corpus callosum (left panel). On axial T2WI 
abnormal periventricular perioccipital signal intensities are seen (right panel). 
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